Clinical Trials Browser

Withdrawn × Rectal Neoplasms × 90 days × Clear all

NCT07223567 2026-02-25

A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms